🏛️ Verified NIH Record • Updated 2026-03-05
Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western Pennsylvania (NCT04085510)
Improving Surveillance of Women With Personal History of Breast Cancer Using Contrast-Enhanced Mammography (CEM)
🔵 Active, Not Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: Wendie Berg
🩺 Plain-English Summary (8th-Grade Level)
This is a prospective clinical trial that will examine if contrast-enhanced mammography substantially improves breast cancer detection compared to mammography with tomosynthesis, with minimal increase in false-positives, in women with a personal history of breast cancer.
Who can join: Review the eligibility criteria below.
Location: Magee Womancare Passavant Cranberry — Cranberry Township, Pennsylvania
Age range: 30 Years to 85 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- Magee Womancare Passavant Cranberry — Cranberry Township, Pennsylvania
- Magee Womancare Monroeville — Monroeville, Pennsylvania
- Magee Womens Hospital — Pittsburgh, Pennsylvania
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Breast Cancer Female
- Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer — Tampa, Florida
- Developing an Internet-Delivered Sexual Health Program for Breast Cancer Survivors, SHINE Trial — Phoenix, Arizona
- Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer — Charlottesville, Virginia
- Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information in Women — Aurora, Colorado
- Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life Outcomes — Detroit, Michigan
- Robotic vs. Open NSM for Early Stage Breast Cancer — Irvine, California
Explore by condition: All Breast Cancer Female clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.